Barclays Increases DexCom (NASDAQ:DXCM) Price Target to $93.00
DexCom (NASDAQ:DXCM – Get Free Report) had its price objective increased by research analysts at Barclays from $90.00 to $93.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the medical device company’s stock. Barclays‘s target price would indicate a potential upside of 13.95% from the company’s previous […]
DexCom (NASDAQ:DXCM – Get Free Report) had its price objective increased by research analysts at Barclays from $90.00 to $93.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the medical device company’s stock. Barclays‘s target price would indicate a potential upside of 13.95% from the company’s previous […]
